Common eye drop ingredient tested to stop cancer Drug's harsh side effect
NCT ID NCT07367178
Summary
This study aims to see if giving atropine, a common medication, can prevent severe diarrhea in people with advanced breast cancer who are being treated with the drug sacituzumab govitecan. It will enroll about 30 adults with specific types of advanced breast cancer that has progressed after other treatments. The main goal is to improve patients' ability to tolerate their cancer therapy by managing this difficult side effect.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.